bnt211
biontech
['solid tumor', 'bnt,211-01', 'bnt211']
the investigational carcinoembryonic antigen claudin 6 directed car t-cell therapy bnt211-01 displayed clinical activity in combination with a cldn6-encoding mrna vaccine in patients with cldn6-positive relapsed/refractory advanced solid tumors. #esmo2022 
Oncology news and insights from leading researchers and cancer centers.